|
Get involved in our clinical trials
Synaps is looking for partners to set up its first multi-centre clinical trials. Do not hesitate to get in touch with us to involve your institution. |
Ongoing clinical trial on PDT supported by Synaps
INDYGO: pilot study to assess feasibility and safety of intraoperative 5-aminolevulinic acid mediated photodynamic (5-ALA PDT) therapy for the treatment of newly diagnosed glioblastoma (GBM)
Other clinical trials involving Synaps partners
RESECT: medico-economic evaluation of surgery guided by fluorescence for the optimization of resection of glioblastomas
Bevacizumab and Lomustine for Recurrent GBM: the primary objective of this study is to investigate whether the addition of bevacizumab to lomustine improves overall survival (OS) in patients with recurrent glioblastoma compared to treatment with lomustine alone
INTELLANCE 2: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma
CheckMate 498: study of Nivolumab Compared to Temozolomide, Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma